Arbutus Biopharma Corp. (ABUS)

4.31 +0.06 (+1.41%) USD  |  NASDAQ  |  Mar 19, 14:20
More

Arbutus Biopharma EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Moderna, Inc. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --